Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis.

Publication

Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis.

Journal Paper/Review - Aug 23, 2022

Siegler James, Shu Liqi, Yaghi Shadi, Omran Setareh Salehi, Elnazeir Marwa, Bakradze Ekaterina, Psychogios Marios-Nikos, De Marchis Gian Marco, Yu Siyuan, Klein Piers, Abdalkader Mohamad, Nguyen Thanh N, ACTION-CVT Investigators

Citation

Siegler J, Shu L, Yaghi S, Omran S, Elnazeir M, Bakradze E, Psychogios M, De Marchis G, Yu S, Klein P, Abdalkader M, Nguyen T, ACTION-CVT Investigators. Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis. Neurosurgery 2022; 91:749-755.

Type

Journal Paper/Review (English)

Journal

Neurosurgery 2022; 91

Publication Date

Aug 23, 2022

Issn Electronic

1524-4040

Pages

749-755

Brief description/objective

Endovascular treatment (EVT) for cerebral vein thrombosis (CVT) has not been proven to be more effective than anticoagulation based on recent results of the Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TO-ACT) randomized clinical trial.